Tuberculosis — Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
Citation(s)
A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Healthy Volunteers Who Are Latently Infected With Mycobacterium Tuberculosis.